Genetic Technologies Acquires EasyDNA
Filed with ASX · · 4 pages · English
Melbourne, Australia, 19 July 2021:Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business advises that it has entered into an agreement to acquire the direct-to-consumer eCommerce business and distribution rights associated with General Genetics Corporation and its associated brands trading as EasyDNA (‘EasyDNA’ or
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- US Patent Office Grants Foundational Pharmacogenomic Patent
- GTG COVID-19 Risk Test launched in USA
- COVID- 19 Risk Test Approved for Commercial Release
- GTG signs 3-year US licence agreement for COVID risk test
- Pause in Trading
Later from Genetic Technologies
- Genetic Technologies Investor Presentation and Webinar
- Completion of EasyDNA Acquisition set for global expansion
- Genetic Technologies FY21 Full Year Results
- Presentation to H.C. Wainwright Investment Conference
- GTG delivers material increase in cash receipts
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies